Subscribe To
Ewq: french equities are fairly valued and unexciting
iShares MSCI France ETF is a fairly concentrated portfolio of French equities, with 64 holdings and assets under management of $1 billion. The fund's ...
Crown castle's improved valuation makes it attractive
Crown Castle is on the cusp of a Sprint-related earnings growth trough. This churn will be a one-time event while tower fundamentals remain in secular...
Taiwan's foxconn predicts huge growth in ai server business
Taiwanese tech giant and key Apple supplier Foxconn predicts three-digit growth for its artificial intelligence server business due to robust demand f...
Udemy: continues to gain share, and ai is not a risk
Udemy rebounds in 1Q23 with higher-than-expected revenue and profit margins, demonstrating growth in its Udemy Business segment and resilience in its ...
Ev maker faraday future launches limited edition ff 91 2.0 for $309,000
Electric vehicle (EV) startup Faraday Future Intelligent Electric launched its limited edition FF 91 2.0 Futurist Alliance vehicle on Tuesday, priced ...
Drax 'confident' in biomass reporting as ofgem opens investigation
Drax said it is “confident” in its biomass compliance after Ofgem opened an investigation into its reporting under the Renewables Obligation schem...
Largo: the remainder of 2023 could be challenging as vanadium prices slide
The Maracas Menchen mine has an NPV of $2 billion according to a 2021 life plan but Largo has been in the red for three consecutive quarters. Heavy ra...
Wh smith plc ups guidance modestly after strong trading
WH Smith PLC (LSE:SMWH) said it continued to perform strongly across all key travel markets as it approaches the peak trading period. In a statement, ...
Ipo update: pineapple financial readies $6 million u.s. micro-ipo
Pineapple Financial has filed proposed terms for a $6.25 million U.S. IPO. The firm provides mortgage processing technologies and brokerage services i...
V.f. corporation: the trend is your friend
V.F. Corp's stock has potential for growth as high inflation eases, consumer spending rises, and COVID restrictions in China no longer apply. The Nort...
Coda octopus: still quite attractive
Coda Octopus Group has promising prospects with its volumetric real-time imaging sonar technology and Diver Augmented Vision Display (DAVD) system, wh...
This video shows how nvidia's ai could transform the experience of talking to video game characters
Nvidia debuted a new AI tool at Computex Taipei that targets the video game experience. The tool could transform the way players interact with non-pla...
7 stocks to buy (and never sell)
Some companies clearly have what it takes to remain leaders in their sectors. Many will never face meaningful competitive threats....
Prudential's cfo quits after code of conduct investigation
Prudential PLC (LSE:PRU)'s Chief Financial Officer James Turner has quit following an investigation into a Code of Conduct issue relating to a "rece...
Boston beer (sam) moves 5.4% higher: will this strength last?
Boston Beer (SAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for th...
Elon musk's visit underscores china's importance to global ev market, analysts say
Elon Musk's visit to Beijing is spotlighting China's place in the global electric vehicle markets....
Cryptocurrencies continue to be dragged by us debt ceiling
Cryptocurrencies continue to be influenced by the debt ceiling drama with Bitcoin and Ethereum losing ground. Bitcoin slipped by 2.1% to US$27,198, wh...
Upstart: the catalyst needed fell into place
Upstart reached a tipping point. Up until a few weeks ago, the business was still being speculated as potentially headed into bankruptcy. Even if the ...
Academy sports and outdoors: recent drop seems exaggerated
Academy Sports has dropped nearly 30% in the past few weeks. The specialty retailer operates in a massive market and continues to see multiple growth ...
Volkswagen won't participate in china discount battle "at any price" - coo
Volkswagen will not participate in a discount battle in China "at any price", Chief Operating Officer Ralf Brandstaetter said in an interview released...
Anglo asian mining reports large high-grade assay to extend mineralisation at gilar project
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) told investors that the latest drill results from the Gilar deposit, in Azerbaijan, have confirmed an exte...
Entain likely to face "substantial" fine from ongoing probe
Entain PLC (LSE:ENT) said it is likely to face a “substantial financial penalty” when the outcome of a four year probe into its former Turkish bus...
Playstudios: gaming growth can improve margins
Playstudios is expected to see mobile gaming growth improve after a slowdown due to overspending during the Covid-19 period, with revenue growth forec...
Aurora innovation: getting ready for commercialization
Aurora Innovation has made significant progress in its technology development, reaching key milestones such as completing Beta 6.0 for the Aurora Driv...
Kefi gold and copper raises £6.4mln as construction nears
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) has completed new funding ahead of the start of building work at Tulu Kapi in Ethiopia. Including a re...
Bloomsbury publishing reports record results as consumers turn to books
Bloomsbury Publishing said it delivered “record results” and forecasts revenues and profits to grow in the current financial year. Sales were up 1...
Challenger energy shows fresh estimates that reaffirm ‘multi billion barrel' potential for uruguay project
Challenger Energy Group PLC (AIM:CEG, OTC:BSHPF) has reported new estimates which estimate that in the ‘upside case' its exploration project offshor...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
5 trillion-dollar companies — including nvidia, apple, and amazon — have been behind most of the s&p 500's 10% gains this year
The S&P 500 index is on a tear, rising nearly 10% this year. But most of the gains are from a quintet of stocks that have surged massively this year....